Company intelligence / Profile preview

Detke Biopharma Consulting LLC

Carmel, Indiana, United Statesmarketscreener.com ↗

Ownership: Private
Employees: ~1
Development stage: Phase 2

Overview

Provides expert consulting in CNS drug development strategy and clinical trial design for pharma/biotech companies and NIH. Led by Dr. Michael J. Detke with extensive experience as CMO at multiple biotechs/pharmas overseeing assets through all phases of development including INDs/NDAs. No proprietary pipeline—consulting only.

Therapeutic areas: PsychiatryNeurology
Modalities: Not directly applicable; provides consulting on CNS drug development across various modalities including small molecules and biologics
Industry: Consulting

Drug pipeline

1 asset

COR388

Phase 2/3

Indications: Alzheimer's disease

Partnerships

Consults for pharmaceutical companies, biotech firms, NIH/NIMH on CNS drug development strategy/design/regulatory affairs. Specific client names not disclosed.

Beyond the preview

Go deeper on Detke Biopharma Consulting LLC.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Detke Biopharma Consulting LLC.

Explore the full profile